A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch model

Abstract Background Rare disease patient-reported outcome measures (PROMs) require linguistic adaptation to overcome the challenge of geographically dispersed patient populations. Importantly, PROMs such as health-related quality of life (HRQoL) should accurately capture responses to patient-identif...

Full description

Bibliographic Details
Main Authors: Agnes Kocher, Mwidimi Ndosi, Kris Denhaerynck, Michael Simon, Andrew A. Dwyer, Oliver Distler, Kirsten Hoeper, Patrizia Künzler-Heule, Anthony C. Redmond, Peter M. Villiger, Ulrich A. Walker, Dunja Nicca
Format: Article
Language:English
Published: BMC 2021-08-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Online Access:https://doi.org/10.1186/s13023-021-01944-9
id doaj-3e9d83106553412db3cb4a7816951e8a
record_format Article
spelling doaj-3e9d83106553412db3cb4a7816951e8a2021-08-15T11:29:56ZengBMCOrphanet Journal of Rare Diseases1750-11722021-08-011611910.1186/s13023-021-01944-9A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch modelAgnes Kocher0Mwidimi Ndosi1Kris Denhaerynck2Michael Simon3Andrew A. Dwyer4Oliver Distler5Kirsten Hoeper6Patrizia Künzler-Heule7Anthony C. Redmond8Peter M. Villiger9Ulrich A. Walker10Dunja Nicca11Institute of Nursing Science (INS), Department Public Health (DPH), Faculty of Medicine, University of BaselSchool of Health and Social Wellbeing, University of the West of EnglandInstitute of Nursing Science (INS), Department Public Health (DPH), Faculty of Medicine, University of BaselInstitute of Nursing Science (INS), Department Public Health (DPH), Faculty of Medicine, University of BaselBoston College, Connell School of NursingDepartment of Rheumatology, University Hospital Zurich, University of ZurichHannover Medical School, Department, Rheumatology and ImmunologyInstitute of Nursing Science (INS), Department Public Health (DPH), Faculty of Medicine, University of BaselLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of LeedsDepartment of Rheumatology, Immunology and Allergology, Inselspital, Bern University Hospital, University of BernDepartment of Rheumatology, University Hospital BaselInstitute of Nursing Science (INS), Department Public Health (DPH), Faculty of Medicine, University of BaselAbstract Background Rare disease patient-reported outcome measures (PROMs) require linguistic adaptation to overcome the challenge of geographically dispersed patient populations. Importantly, PROMs such as health-related quality of life (HRQoL) should accurately capture responses to patient-identified concerns. The Systemic Sclerosis Quality of Life Questionnaire (SScQoL) is a 29-item tool validated in six languages. Previous evaluation of the German version revealed problems with dichotomous responses. This study aimed to revise the German SScQoL, extend the response structure, and evaluate content and construct validity, reliability and unidimensionality. Methods The instrument validation study involved revising the German SScQoL response structure, cognitive debriefing with patients and validation using Rasch analysis. The revised SScQoL was completed by Swiss-German-speaking patients with SSc within the Swiss MANagement Of Systemic Sclerosis (MANOSS) study. Rasch analysis was employed to test the validity, reliability and unidimensionality of the revised instrument. Results Based on cognitive debriefing with patients (n = 6) dichotomous items were extended to a polytomous 4-point response structure. A total of 78 patients completed the revised SScQoL. Initial analysis of the 29 items suggested the scale lacked fit to the model (χ2 = 51.224, df = 29, p = 0.007). Grouping items into five domains resulted in an adequate fit to the Rasch model (χ2 = 5.343, df = 5, p = 0.376) and unidimensionality (proportion of significant independent t tests: 0.045, 95% CI 0.016–0.114). Overall, the scale was well targeted, had high internal consistency (Person Separation Index, PSI = 0.931) and worked consistently in patients with different demographic and clinical characteristics. Conclusions The revised German SScQoL has a 4-point response structure and is a valid, reliable measure. Rasch analysis is useful for validating continuous response structure of quality of life measures. Further evaluation of measurement equivalence with other German-speaking cultures is required for multinational comparisons and data pooling.https://doi.org/10.1186/s13023-021-01944-9Health-related quality of lifeItem response theoryMethodologyPatient-centered carePatient reported outcome measuresRare diseases
collection DOAJ
language English
format Article
sources DOAJ
author Agnes Kocher
Mwidimi Ndosi
Kris Denhaerynck
Michael Simon
Andrew A. Dwyer
Oliver Distler
Kirsten Hoeper
Patrizia Künzler-Heule
Anthony C. Redmond
Peter M. Villiger
Ulrich A. Walker
Dunja Nicca
spellingShingle Agnes Kocher
Mwidimi Ndosi
Kris Denhaerynck
Michael Simon
Andrew A. Dwyer
Oliver Distler
Kirsten Hoeper
Patrizia Künzler-Heule
Anthony C. Redmond
Peter M. Villiger
Ulrich A. Walker
Dunja Nicca
A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch model
Orphanet Journal of Rare Diseases
Health-related quality of life
Item response theory
Methodology
Patient-centered care
Patient reported outcome measures
Rare diseases
author_facet Agnes Kocher
Mwidimi Ndosi
Kris Denhaerynck
Michael Simon
Andrew A. Dwyer
Oliver Distler
Kirsten Hoeper
Patrizia Künzler-Heule
Anthony C. Redmond
Peter M. Villiger
Ulrich A. Walker
Dunja Nicca
author_sort Agnes Kocher
title A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch model
title_short A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch model
title_full A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch model
title_fullStr A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch model
title_full_unstemmed A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch model
title_sort rare disease patient-reported outcome measure: revision and validation of the german version of the systemic sclerosis quality of life questionnaire (sscqol) using the rasch model
publisher BMC
series Orphanet Journal of Rare Diseases
issn 1750-1172
publishDate 2021-08-01
description Abstract Background Rare disease patient-reported outcome measures (PROMs) require linguistic adaptation to overcome the challenge of geographically dispersed patient populations. Importantly, PROMs such as health-related quality of life (HRQoL) should accurately capture responses to patient-identified concerns. The Systemic Sclerosis Quality of Life Questionnaire (SScQoL) is a 29-item tool validated in six languages. Previous evaluation of the German version revealed problems with dichotomous responses. This study aimed to revise the German SScQoL, extend the response structure, and evaluate content and construct validity, reliability and unidimensionality. Methods The instrument validation study involved revising the German SScQoL response structure, cognitive debriefing with patients and validation using Rasch analysis. The revised SScQoL was completed by Swiss-German-speaking patients with SSc within the Swiss MANagement Of Systemic Sclerosis (MANOSS) study. Rasch analysis was employed to test the validity, reliability and unidimensionality of the revised instrument. Results Based on cognitive debriefing with patients (n = 6) dichotomous items were extended to a polytomous 4-point response structure. A total of 78 patients completed the revised SScQoL. Initial analysis of the 29 items suggested the scale lacked fit to the model (χ2 = 51.224, df = 29, p = 0.007). Grouping items into five domains resulted in an adequate fit to the Rasch model (χ2 = 5.343, df = 5, p = 0.376) and unidimensionality (proportion of significant independent t tests: 0.045, 95% CI 0.016–0.114). Overall, the scale was well targeted, had high internal consistency (Person Separation Index, PSI = 0.931) and worked consistently in patients with different demographic and clinical characteristics. Conclusions The revised German SScQoL has a 4-point response structure and is a valid, reliable measure. Rasch analysis is useful for validating continuous response structure of quality of life measures. Further evaluation of measurement equivalence with other German-speaking cultures is required for multinational comparisons and data pooling.
topic Health-related quality of life
Item response theory
Methodology
Patient-centered care
Patient reported outcome measures
Rare diseases
url https://doi.org/10.1186/s13023-021-01944-9
work_keys_str_mv AT agneskocher ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel
AT mwidimindosi ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel
AT krisdenhaerynck ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel
AT michaelsimon ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel
AT andrewadwyer ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel
AT oliverdistler ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel
AT kirstenhoeper ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel
AT patriziakunzlerheule ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel
AT anthonycredmond ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel
AT petermvilliger ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel
AT ulrichawalker ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel
AT dunjanicca ararediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel
AT agneskocher rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel
AT mwidimindosi rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel
AT krisdenhaerynck rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel
AT michaelsimon rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel
AT andrewadwyer rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel
AT oliverdistler rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel
AT kirstenhoeper rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel
AT patriziakunzlerheule rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel
AT anthonycredmond rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel
AT petermvilliger rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel
AT ulrichawalker rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel
AT dunjanicca rarediseasepatientreportedoutcomemeasurerevisionandvalidationofthegermanversionofthesystemicsclerosisqualityoflifequestionnairesscqolusingtheraschmodel
_version_ 1721206726401720320